{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18488453", "DateCompleted": {"Year": "2008", "Month": "07", "Day": "24"}, "DateRevised": {"Year": "2016", "Month": "10", "Day": "20"}, "Article": {"Language": ["rus"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0869-6047", "JournalIssue": {"Issue": "4", "PubDate": {"Year": "2008"}}, "Title": "Vestnik Rossiiskoi akademii meditsinskikh nauk", "ISOAbbreviation": "Vestn Ross Akad Med Nauk"}, "ArticleTitle": "[Conservative methods in the therapy of male sterility. Critical analysis].", "Pagination": {"StartPage": "27", "EndPage": "34", "MedlinePgn": "27-34"}, "Abstract": {"AbstractText": ["The treatment of 126 patients with male sterility was analyzed. The low efficiency of therapy with hormonal and nonhormonal drugs in patients with testicular form of sterility was observed. The same patients clinically underwent general (intravenous) ozonotherapy. After one course (10 intravenous injections) stable positive clinicolaboratorial effect (increase of sperm density and qualitative characteristics of gametes) was detected in 28% patients. After 2-3 courses (with intervals of 3 months) positive dynamics was observed in almost 70% cases. Thus, general ozonotherapy should be considered as one of effective technologies of treatment in patients with male sterility."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Artiukhin", "ForeName": "A A", "Initials": "AA"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Russia (Federation)", "MedlineTA": "Vestn Ross Akad Med Nauk", "NlmUniqueID": "9215641", "ISSNLinking": "0869-6047"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Androgens"}, {"RegistryNumber": "0", "NameOfSubstance": "Chorionic Gonadotropin"}, {"RegistryNumber": "0", "NameOfSubstance": "Profasi"}, {"RegistryNumber": "3XMK78S47O", "NameOfSubstance": "Testosterone"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "H16A5VCT9C", "NameOfSubstance": "testosterone undecanoate"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Androgens"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Chorionic Gonadotropin"}, {"QualifierName": [], "DescriptorName": "Combined Modality Therapy"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy", "etiology", "therapy"], "DescriptorName": "Infertility, Male"}, {"QualifierName": [], "DescriptorName": "Life Style"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Magnetics"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Occupational Exposure"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemistry"], "DescriptorName": "Spermatozoa"}, {"QualifierName": ["analogs & derivatives", "therapeutic use"], "DescriptorName": "Testosterone"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "5", "Day": "21", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "7", "Day": "25", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "5", "Day": "21", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18488453"]}}], "PubmedBookArticle": []}